Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 96, Issue 4, 1997, Pages 697-707

  Wall, D M P ^a   El Osta, S ^a   Tzelepis, D ^b   Bertoncello, I ^b   Kantharidis, P ^a   Chou, S T ^a   Zalcberg, J R ^a   Parkin, J D ^a  

^a AUSTIN HEALTH   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

B CLL; mdr1; normal B cell homologues

Indexed keywords

ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0031049270     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2090.x     Document Type: Article

References (63)

1. Barrand, M.A., Heppell-Parton, A.C., Wright, K.A., Rabbitts, P.H. & Twentyman, P.R. (1994) A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. Journal of the National Cancer Institute, 86, 110-117.
2. Beck, J., Niethammer, D. & Gekeler, V. (1994) High mdr1- and mrp-, but low topoisomerase II alpha gene expression in B-cell chronic lymphocytic leukaemias. Cancer Letters, 86, 135-142.
3. Beletsky, I.P. & Umansky, S.R. (1990) A new assay for cell death. Journal of Immunological Methods, 134, 201-205.
4. Bennett, J.M., Catovsky, D., Daniel, M-T., Flandrin, G., Galton, D.A.G., Gralnick. H.R. & Sultan, C., the French-American-Brilish (FAB) Cooperative Group (1989) Proposals for the classification of chronic (mature) B and T lymphoid malignancies. Journal of Clinical Pathology, 42, 567-584.
5. Bofill, M., Janossy, G., Janossa, M., Burford, G.D., Seymour, G.J., Wernet, P. & Kelemen, E. (1985) Human B-cell development. II. Subpopulations in the human fetus. Journal of Immunology, 134, 1531-1538.
6. Boumsell, L., Coppin, H., Pham, D., Raynal, B., Lemerle, J., Dausset, J. & Bernard, A. (1980) An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Journal of Experimental Medicine, 152, 229-234.
7. Burger, H., Nooter, K., Zaman, G.J.R., Sonneveld, P., van Wingerden, K., Oostrum, R.G. & Stoter, G. (1994) Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia, 8, 990-997.
8. Caligaris-Cappio, F., Gobbi, M., Bofill, M. & Janossy, G. (1982) Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. Journal of Experimental Medicine, 155, 623-628.
9. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, U. & Fiere, D. (1992) Clinical significance of multidrug resistance and P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473-476.
10. Carbone, A., Gloghini, A., Volpe, R., Attadia, V., Gattei, V. Zagoncl, V. & Pinto, A. (1992) Follicular lymphoma of compartmentalized small cleaved center cells and mantle zone lymphocytes. American Journal of Clinical Pathology, 98, 437-448.
11. Chaudhary, P.M., Mechetner, E.B. & Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735-2739.
12. Cheng, A.L., Su, I.J., Chen, Y.C., Lee, T.C. & Wang, C.H. (1993) Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors. Journal of Clinical Oncology, 11, 109.
13. Chin, K.-V., Ueda, K., Pastan, I. & Gottesman, M.M. (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science, 255, 459-462.
14. Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz. E.U., Duncan, A.M.V. & Deeley, R.G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
15. Cong, Y.Z., Rabin, E. & Wortis, H.H. (1991) Treatment of murine CD5-B cells with anti-Ig but not LPS induces surface CD5. International Immunology, 3, 467-476.
16. Coon, J.S., Wang, Y. & Bines, S.D. (1991) Multidrug resistance activity in human lymphocytes. Human Immunology, 32, 134-140.
17. Cordon-Cardo, C., O'Brien, J., Boccia, J., Casals, D., Bertino, J.R. & Melamed, J.R. (1990) Expression of the multidrug resistance gene product in human normal and tumor tissues. Journal of Histochemistry and Cytochemistry, 38, 1277-1287.
18. Cumber, P.M., Jacobs, A., Hoy, T., Fisher, J., Whittaker, J.A., Tsuruo, T. & Padua, R.A. (1990) Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia. British Journal of Haematology, 76, 226-230.
19. Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H. & Andreff, M. (1992) Subpopulations of normal peripheral and bone marrow cells express a functional multidrug resistant phenotype. Blood, 80, 2729-2734.
20. Epstein, J., Xiao, H. & Oba, B.K. (1989) P-glycoprolein expression in plasma cell myeloma is associated with resistance to VAD. Blood, 74, 913-917.
21. Feller, N., Kuiper, C.M., Lankelma, J., Ruhdal, J.K., Scheper, R.J., Pinedo, H.M. & Broxterman, H.J. (1995) Functional detection of mdr1/p170 and mrp/p190-mediated multidrug resistance in tumour cells by flow cytometry. British Journal of Cancer, 72, 543-549.
22. Fojo, A., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. & Pastan, I. (1987) Expression of a multidrug resistance gene in human tumors and tissues. Proceedings of the National Academy of Sciences of the United States of America, 84, 265-269.
23. Freedman, A.S., Boyd, A.W., Bieber, F.R., Daley, J., Rosen, K., Horowitz, J.C., Levy, D.N. & Nadler, L.M. (1987) Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood, 70, 418-427.
24. Futscher, B.W., Blake, L. & Gerlach, J.H. (1993) Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Analytical Biochemistry, 213, 414-421.
25. Geisler, G.H., Larsen, J.K., Hansen, N.E., Hansen, M.M., Christensen, B.E., Lund, B., Nielsen, H., Plesner, T., Thorling, K., Andersen, E. & Andersen, P.E. (1991) Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78, 1745-1802.
26. Goldstein, L.J., Galski, H., Fojo, A., Willingham, M., Lai, S.L., Gazdar, A., Pirker, R., Green, A., Crist, W. & Brodeur, G.M. (1989) Expression of a multidrug resistance gene in human cancers. Journal of the National Cancer Institute, 81, 116-124.
27. Herweijer, H., Sonneveld, P., Baas, F. & Nooter, K. (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. Journal of the National Cancer Institute, 82, 1133-1140.
28. Hyde. S.C., Emsley, P., Hartshorn, M.J., Mimmack, M.M., Gileadi, U., Pearce, S.R., Gallagher, M.P., Gill, D.R., Hubbard, R.E. & Higgins, C.F. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 346, 362-365.
29. Hu, X.F., Slater, A., Wall, D.M., Kantharidis, P., Parkin, J.D., Cowman, A. & Zalcberg, J.R. (1995) Rapid upregulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. British Journal of Cancer, 71, 931-936.
30. International Workshop on Chronic Lymphocytic Leukemia (1989) Chronic lymphocytic leukemia, recommendations for diagnosis, staging and response criteria. Annals of Internal Medicine, 110, 236-238.
31. Kamoun, M., Kadin, M.F., Martin, P.J., Nettleton, J. & Hansen, J.A. (1981) A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. Journal of Immunology, 127, 987-991.
32. Kanamaru, H., Kakehi, Y., Yoshida, O., Nakanishi, S., Pastan, I. & Gottesman, M.M. (1989) MDR1 mRNA levels in human renal cell carcinoma: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. Journal of the National Cancer Institute. 81, 844-849.
33. Kessel, D., Beck, W.T., Kukuruga, D. & Schulz, V. (1991) Characterization of multidrug resistance by fluorescent dyes. Cancer Research, 51, 4665-4670.
34. Kipps, T.J. & Duffy, S.F. (1991) Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes. Journal of Clinical Investigation, 87, 2087-2096.
35. Lee, J.S., Paull, K., Alvarez, M., Hose, C., Monks, A., Grever, M., Fojo, A.T. & Bates, S.E. (1994) Rhodamine efflux patterns predict P-glycoprotein substrates in the national cancer drug screen. Molecular Pharmacology, 46, 627-638.
36. Ludescher, C., Hilbe, W., Eisterer, E., Preuss, E., Huber, C., Gotwald, M., Hofman, J. & Thaler, J. (1993) Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric analysis. Journal of the National Cancer Institute, 85, 1751-1758.
37. + B-cells and the immune system. Immunology Letters. 38, 159-166.
38. + (B1) B-cells in health and disease. Fundamental and Clinical Immunology, 2, 9-21.
39. Marie, J.P. Delmer, A. & Zittoun, R. (1994) Mdr1 expression in B and T lymphocytes in 13-cell lymphoproliferative disorders. Proceedings of the American Association for Cancer Research, 10, 11.
40. Martin, P.J., Hansen, J.A., Nowinski, R.C. & Brown, M.A. (1980) A new human T cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics, 11, 429-439.
41. McGrath, T. & Center, M.S. (1987) Adriamycin resistance in HL60 in the absence of detectable P-glycoprotein. Biochemical Research Communications, 145, 1171-1176.
42. Michieli, M., Raspadori, D., Damiani, D., Geromin, A., Gallizia, C., Michelutti, A., Fanin, R., Fasola, G., Russo, D. & Tazzari, P. (1991) The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 77, 460-465.
43. Miller, T.P., Grogan, T.M., Dalton, W.S., Spier, C.H., Scheper, R.J. & Salmon, S.E. (1991) P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. Journal of Clinical Oncology, 9, 17-24.
44. Muller, M., Twentyman, P.R., Lambert, E. & Rees, J.K.H. (1990) A multifactorial approach to the study of drug resistance in cells from leukaemia patients. British Journal of Haematology, 74, (Suppl. 1), 5.
45. Niehans, G.A., Jaszcz, W., Brunetto, V., Perri, R.T., Gajl-Peczalska, K., Wick, M.R., Tsuruo, T. & Bloomfield, C.D. (1992) Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas. Cancer Research, 52, 3768-3775.
46. Nooter, K. & Sonneveld, P. (1994) Clinical relevance of P-glycoprotein expression in hematological malignancies. Leukemia Research, 18, 233-243.
47. Pastan, I. & Gottesman, MM. (1987) Multi-drug resistance in human cancer. New England Journal of Medicine, 316, 1388-1393.
48. Perri, R.T., Louie, S.W. & Espar, W.G. (1990) Relationship of the multidrug resistance (mdr) gene mdr1 in chronic lymphatic leukaemia (CLL) B cells to in vitro drug resistance/sensitivity. Blood, 76, (Suppl. 1), 308.
49. Pileri, S.A., Sabattini, K., Falini, B., Tazzari, P.L., Gherlinzoni, F., Michaeli, M.G., Damiani, D., Zucchini, L., Gobbi, M. & Tsuruo, T. (1991) Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathology, 19, 131-140.
50. Poje, E., Bierman, P., Daley, D., Hale, C. & Weisenburger, D. (1991) Expression of P-glycoprotein in B-cell non-Hodgkin's lymphoma. Proceedings of the American Association for Cancer Research, 32, 367.
51. +. Journal of Immunology, 148, 3398-3404.
52. Segal, G.H., Masih, A.S., Fox, A.C., Jorgensen, T., Scott, M. & Braylan, R.C. (1995) CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood, 85, 1570-1579.
53. Schlauer, D., Laurent, G., Chittal, S., Tsuruo, T., Soues, S., Muller, C., Charcosset, J.Y., Alard, C., Brousset, P. & Mazerolles, C. (1990) Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. British Journal of Cancer, 62, 177-182.
54. Shustik, C., Groulx, N. & Gros, P. (1991) Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphatic leukaemia (CLL). British Journal of Haematoloay, 79, 50-56.
55. Sparrow, R.L., Hall, F.J., Siregar, H. & Van der Weyden, M.B. (1993) Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphatic leukemia and correlation with in-vitro drug resistance. Leukaemia Research, 17, 941-947.
56. Speeg, K., Maldonado, A., Liaci, J. & Muirhead, D. (1992a) Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo. Journal of Pharmacology and Experimental Therapeutics, 261, 750-755.
57. Speeg, K., Maldonado, A., Liaci, J. & Muirhead, D. (1992b) Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology, 15, 899-903.
58. Ternyck, T., Dighiero, G., Follezou, J. & Binet, J.-L. (1974) Comparison of normal and CLL lymphocyte Ig determinants using peroxidase labeled antibodies. I. detection and quantitation of light chain determinants. Blood, 43, 789-795.
59. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M., Pastan, I. & Willingham, M.C. (1987) Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the United States of America, 84, 7735-7738.
60. Thilaganathan, B., Nicolaides, K.H., Mansur, C.A., Levinsky, R.J. & Morgan, G. (1993) Fetal B lymphocyte subpopulations in normal pregnancies. Fetal Diagnosis and Therapy, 8, 15-21.
61. Van der Bliek, A.M., Kooiman, P.M., Scneider, C. & Borst, P. (1988) Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene, 71, 401-411.
62. Wall, D.M., Sparrow, R., Xiu, F.H., Nadalin, G., Zalcberg. J.R., Marschner, I.C., Van der Weyden, M. & Parkin, J.D. (1993) Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3, European Journal of Cancer, 29A, 1024-1027.
63. Zalcberg, J.R., Hu, X.F., Wall, D.M., Mirski, S., Cole, S., Nadalin, G., De Luise, M., Parkin, J.D., Vrazas, V., Campbell, L. & Kantharidis, P. (1994) Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line. International Journal of Cancer, 57, 522-528.